FX Alliance Jumps On Acquisition (SLB, FX, NSPH, MOH, AMPE)

FX Alliance Jumps On Acquisition (SLB, FX, NSPH, MOH, AMPE)

Schlumberger Limited. (NYSE:SLB) went down 0.14% to $65.08. Anton Oilfield Services Ltd announced that it has received a corporate substantial shareholder notice filed by Schlumberger NV pursuant to section 324 of Part XV of the Securities and Futures Ordinance that Schlumberger has acquired 423,361,944 shares in Anton Oilfield Services. This represents 20.10% of the issued share capital of Anton Oilfield Services on July 6, 2012.

FX Alliance Inc (NYSE:FX) jumped up 39.62% to $21.92 on a traded volume of 1.33 million shares. Thomson Reuters Corp is acquiring electronic foreign exchange trading services provider FX Alliance Inc for about $623 million. FX Alliance currently has more than 1,300 institutional clients. Thomson Reuters will pay $22 per share, reflecting 40% premium to FX Alliance’s closing price of $15.70 on 6th July 2012.

Nanosphere Inc (NASDAQ:NSPH) augmented 6.27% to $3.39. Roth Capital upgraded the rating on the stock from neutral to buy. Recently, the U.S. Food and Drug Administration have granted a de novo petition permitting marketing of its Gram-Positive Blood Culture Nucleic Acid Test on the automated sample-to-result Verigene System.

Molina Healthcare Inc (NYSE:MOH) augmented 13.09% to $26.09. The Company will report its earnings for the second quarter and six months ended June 30, 2012 on July 26, 2012. Molina Healthcare, Inc. provides Medicaid-related solutions to meet the health care needs of low-income families and individuals, and to assist state agencies in their administration of the Medicaid program. The Company’s business focuses on government-sponsored health care programs, and includes its Health Plans segment, its Molina Medicaid Solutions segment, and smaller direct delivery line of business.

Ampio Pharmaceuticals Inc (NASDAQ:AMPE) increased 5.61% to $5.11. The Company announced the significant results from their further analysis of its Optina trial on DME. The primary endpoint was change from baseline to week twelve of treatment in retinal thickness as measured by Optical Coherence Tomography.